Hangzhou Alltest Biotech Co Ltd (688606)

Currency in CNY
68.95
+1.65(+2.45%)
Closed·
688606 Scorecard
Full Analysis
Has a perfect Piotroski Score of 9
High dividend Yield
688606 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
67.0169.08
52 wk Range
60.4084.72
Key Statistics
Bid/Ask
68.81 / 68.95
Prev. Close
67.3
Open
67.5
Day's Range
67.01-69.08
52 wk Range
60.4-84.72
Volume
751.25K
Average Volume (3m)
784.76K
1-Year Change
3.34%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688606 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Hangzhou Alltest Biotech Co Ltd Company Profile

Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products. Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters. In addition, the company offers SARS-COV-2 RT-qPCR assays, virus specimen stabilizers, and viral DNA/RNA extraction kits; and other test products. Its products are used in clinical testing, on-site testing, personal health management, and other fields. Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is based in Hangzhou, China.

Employees
960
Market
China

Compare 688606 to Peers and Sector

Metrics to compare
688606
Peers
Sector
Relationship
P/E Ratio
17.3x17.2x−0.7x
PEG Ratio
0.510.980.00
Price/Book
1.4x2.1x2.6x
Price / LTM Sales
6.0x7.9x3.4x
Upside (Analyst Target)
-18.7%35.7%
Fair Value Upside
Unlock−0.4%4.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.93%
Dividend Yield
4.35%
Industry Median 1.66%
Annualised payout
3.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 29, 2025
EPS / Forecast
0.90 / --
Revenue / Forecast
221.37M / --
EPS Revisions
Last 90 days

688606 Income Statement

FAQ

What Stock Exchange Does Hangzhou Alltest Biotech Co Trade On?

Hangzhou Alltest Biotech Co is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Hangzhou Alltest Biotech Co?

The stock symbol for Hangzhou Alltest Biotech Co is "688606."

What Is the Hangzhou Alltest Biotech Co Market Cap?

As of today, Hangzhou Alltest Biotech Co market cap is 5.37B.

What Is Hangzhou Alltest Biotech Co's Earnings Per Share (TTM)?

The Hangzhou Alltest Biotech Co EPS (TTM) is 3.93.

When Is the Next Hangzhou Alltest Biotech Co Earnings Date?

Hangzhou Alltest Biotech Co will release its next earnings report on 26 Oct 2025.

From a Technical Analysis Perspective, Is 688606 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Hangzhou Alltest Biotech Co Stock Split?

Hangzhou Alltest Biotech Co has split 1 times.

How Many Employees Does Hangzhou Alltest Biotech Co Have?

Hangzhou Alltest Biotech Co has 960 employees.

What is the current trading status of Hangzhou Alltest Biotech Co (688606)?

As of 08 Oct 2025, Hangzhou Alltest Biotech Co (688606) is trading at a price of 68.95, with a previous close of 67.30. The stock has fluctuated within a day range of 67.01 to 69.08, while its 52-week range spans from 60.40 to 84.72.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.